Parkinson's UK and the University of Sheffield have launched a new £1million virtual biotech company, Keapstone Therapeutics, to combine world-leading research from the University with funding and expertise from the charity to develop new treatments.
Researchers have discovered a potential way to tell the difference between people with Parkinson's and those with parkinsonisms using a simple blood test.
A natural molecule called squalamine may hold the key to preventing Lewy bodies forming in Parkinson's, according to groundbreaking new research.
Gut microbes could play a critical role in the development of Parkinson's, according to groundbreaking new research published on Thursday 1 December.
A research team at Imperial College are testing the use of high-intensity, focused ultrasound waves for the first time in the UK to treat tremor.